Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed with results

Key Signals

1 with results92% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 3 (1)
P 4 (1)

Trial Status

Completed11
Unknown6
Recruiting5
Not Yet Recruiting1
Active Not Recruiting1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07571096Recruiting

Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia

NCT07372170Recruiting

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

NCT04398628Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04537416Active Not RecruitingPrimary

Fertility, Hypercoagulability, and Inflammation (FREYA) Registry

NCT07108023Not Yet Recruiting

Hematological Disorders in EHPVO Patients

NCT06727669Recruiting

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

NCT06171984UnknownPrimary

Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal

NCT00883272Completed

Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women

NCT05853796Recruiting

Observational Dutch Young Symptomatic StrokE studY - nEXT

NCT05551078Unknown

Thrombophilia Screening After Severe IUGR

NCT05225155Completed

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment

NCT04519398Unknown

Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events

NCT01905748Not ApplicableUnknown

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine

NCT02407730Completed

EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies

NCT03682419Not ApplicableCompleted

Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)

NCT02139670CompletedPrimary

Thrombin Generation and Gestational Outcome

NCT00356434Not ApplicableTerminatedPrimary

A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population

NCT01487291Completed

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

NCT00967382Phase 3Completed

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

NCT01372553Completed

Guilford Genomic Medicine Initiative (GGMI)

Scroll to load more

Research Network

Activity Timeline